News
In a powerful talk with Mathew Knowles and Courtney Bugler, CEO of Zero Prostate Cancer, we highlight the urgent need for awareness among Black men at risk.
Cedric Pobel, MD, discusses how the results of the PEACE-1 trial support the use of radiotherapy plus standard of care and abiraterone in low-volume metastatic castration-sensitive prostate cancer.
21h
Medical Device Network on MSNMiraDx test for radiation therapy toxicity validated in new studyProstox test is used to predict radiation side effects in prostate cancer patients based on their unique genetic profiles.
Following recent U.S. Food and Drug Administration (FDA) approval 2, and in preparation for commercial launch in H1 2025, Telix has contracted with Cardinal Health to enable availability across a wide ...
Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...
Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.
Investigators assessed whether a reported survival disadvantage in men with secondary rectal cancer following prostate cancer radiation therapy vs primary rectal cancer is due to patient ...
Real Housewives of Beverly Hills alum Teddi Mellencamp celebrated the end of her radiation treatments as she continues to ...
Moderately hypofractionated and conventionally fractionated radiotherapy demonstrate similar efficacy, but one ...
Real Housewives of Beverly Hills alum Teddi Mellencamp shared more bad news amid her ongoing battle with cancer as doctors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results